MedPath

The Effects of Dexmedetomidine Or Remifentanyl Continuous Infusion on End-Tidal Sevoflurane Concentration In patients undergoing Laparoscopic Cholecestectomies, Monitored by Bispectral Analysis

Not Applicable
Not yet recruiting
Conditions
Surgery
laparoscopic cholecystectomies
Registration Number
PACTR201611001829308
Lead Sponsor
Tanta Univercity Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

ASA I-II patients scheduled for elective Videolaparoscopic cholecystectomy were included

Exclusion Criteria

). Patients were excluded if they had severe cardiac disease, chronic obstructive lung disease, renal and hepatic insufficiency, endocrine, metabolic or central nervous system disorders, a-2-agonist or antagonist therapy taken, and active upper respiratory infection, those receiving medications known to affect MAC, or having a history of alcohol or drug abuse; and women who were lactating or pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.